Abacavir and lamivudine are antiretroviral agents. Both of these medicines are nucleoside reverse transcriptase inhibitors (NRTIs). The combination of abacavir and lamivudine is used for the treatment of HIV infections in combination with other antiretroviral agents.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Other | 1 |
|
1 | ||||
| Emotional tension | 1 | 0 |
Mouse over the table for more information
| 600 mg-300 mg daily | ||
|---|---|---|
2
|
||
Currently Taking Abacavir-Lamivudine
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 23, 2009.